Atlas Trials

Comparison of Two Combinations in Antiretroviral Post-Exposure Prophylaxis for HIV-1: Tenofovir/Emtricitabine (Truvada ®) + Lopinavir/Ritonavir (Kaletra ®) vs Tenofovir/Emtricitabine/Cobicistat/Elvitegravir (Stribild ®). Prospective, Randomized, Open.

Clinical trial NCT02198443 · COMPLETED

Trial details

NCT number
NCT02198443
Sponsor
Fundacion Clinic per a la Recerca Biomédica
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HIV
Start date
2015-06-06
Primary completion
2016-07-15
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.